This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
October 21 - 23, 2024
Presented in Japan Standard Time

The Westin Miyako Kyoto
Delivered as a Hybrid Event

Dr. Hiroko Yamashita, PhD
Senior Scientist, Mid-Size Molecule Unit at Chugai Pharmabody Research
Speaker

Profile

Hiroko Yamashita received her B.E. and M.E. degrees in biomolecular engineering from Tokyo Institute of Technology, Japan, in 2014 and 2016, respectively, and her Ph.D. in pharmaceutical sciences from the University of Tokyo, Japan, in 2019. After that, she joined Chugai Pharmaceutical Co., Ltd. and moved to Chugai Pharmabody Research Pte. Ltd. as a senior scientist in 2022. Her work focuses specifically on the new technology development for discovering peptide-based drugs.